Svetlana Lucas is Director at Jasper Therapeutics, Inc. (JSPR). They have made 2 open-market trades across 2 companies since 2025, most recently 2026-07-23.
CIK 0001781292
2 open-market purchases totalling $94K since 2025, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LIFE | 6,000 | $225K |
| SCTX | 3,000 | $61K |
| JSPR | 20,000 | $10K |
| Total | $295K |
Shares reported on the most recent Form 4, priced at the 2026-07-27 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.